Managements and outcomes of hospitalized heart failure patients with paroxysmal vs nonparoxysmal atrial fibrillation in Taiwan

Keyphrases

• Taiwan 100%
• Heart Failure Hospitalization 100%
• Heart Failure Patients 100%
• Paroxysmal 100%
• Non-paroxysmal Atrial Fibrillation 100%
• Paroxysmal AF 100%
• Atrial Fibrillation 80%
• Non-paroxysmal 80%
• Heart Failure 40%
• 1-year Outcome 40%
• Patients with Heart Failure 40%
• Death Rate 40%
• Heart Failure with Preserved Ejection Fraction (HFpEF) 20%
• Acute Heart Failure 20%
• Beta-blockers 20%
• Taiwanese 20%
• National Database 20%
• Renin-angiotensin System 20%
• Chronic Kidney Disease 20%
• Extracted Data 20%
• Amiodarone 20%
• Paroxysmal Atrial Fibrillation 20%
• Atrial Fibrillation Type 20%
• Optimal Treatment 20%
• At Discharge 20%
• Arrhythmic Death 20%
• Medical Therapy 20%
• Anticoagulants 20%
• Baseline Characteristics 20%
• Prognostic Significance 20%
• Left Atrial Diameter 20%
• CHA2DS2-VASc Score 20%
• Antiplatelet Agents 20%
• Ischemic Cardiomyopathy 20%
• Guideline-directed Medical Therapy 20%
• 1-year Mortality 20%
• Antiarrhythmic Agents 20%
• Heart Failure Death 20%

Medicine and Dentistry

• Atrial Fibrillation 100%
• Congestive Heart Failure 100%
• Mortality Rate 28%
• Heart Failure with Reduced Ejection Fraction 14%
• Acute Decompensated Heart Failure 14%
• Antiarrhythmic Agent 14%
• Chronic Kidney Disease 14%
• Combination Therapy 14%
• Amiodarone 14%
• Paroxysmal Atrial Fibrillation 14%
• CHA2DS2-VASc Score 14%
• Antiplatelet Drug 14%
• Ischemic Cardiomyopathy 14%
• Anticoagulant 14%

Pharmacology, Toxicology and Pharmaceutical Science

• Atrial Fibrillation 100%
• Congestive Heart Failure 100%
• Mortality Rate 28%
• Acute Heart Failure 14%
• Anticoagulant Agent 14%
• Combination Therapy 14%
• Antiarrhythmic Agent 14%
• Chronic Kidney Failure 14%
• Amiodarone 14%
• Paroxysmal Atrial Fibrillation 14%
• Antithrombocytic Agent 14%
• Heart Failure with Reduced Ejection Fraction 14%
• Ischemic Cardiomyopathy 14%